Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines,…

Dental Implants Global Market Report 2021

 The “Dental Implants Global Market Report 2021: COVID-19 Growth and Change to 2030” report has been added to ResearchAndMarkets.com’s offering.…

Worldwide Neurosurgery Devices Industry to 2026

 The “Neurosurgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added…

Global Endoscopy Device Market (2021 to 2026) – Featuring Arthrex, Conmed and Olympus Among Others

The “Endoscopy Device Market – Forecasts from 2021 to 2026” report has been added to ResearchAndMarkets.com’s offering.  The endoscopy devices…

Global Bone Densitometers Market Report 2021-2027 – Rising Demand for Total Scan DXA Methods

Amid the COVID-19 crisis, the global market for Bone Densitometers estimated at US$890.1 Million in the year 2020,…

Beacon Oral Specialists Announces Two Strategic Partnerships in Southern California

Orange County Centers for Oral Surgery (OCCOS) and Desert Oral Surgery, both well-respected and nationally recognized…

Global Dermatology Drugs Market to 2027 – Industry Analysis, Trends, Market Size, and Forecasts

The “Dermatology Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027” report has been…

Glucose Health, Inc. Fiscal 2021 6-Month Update; Zero Debt, Zero Liabilities, Fully Diluted Share Count Reduced by 1/3

Glucose Health, Inc. (OTC: “GLUC”) (“Company”) is pleased to expand upon key financial information pertaining to…

Calliditas Therapeutics has resolved on a directed share issue in the amount of 2.4 million shares, raising proceeds of approximately SEK 324 million

 Calliditas Therapeutics AB (publ) (“Calliditas” or the “Company”) (Nasdaq Stockholm: CALTX) (Nasdaq: CALT), a biopharma company focused on identifying,…

Highmark Health reports over $10 billion in revenue and $585 million in consolidated earnings1 through first two quarters of 2021

Highmark Health today announced financial results for the first six months of 2021, reporting an excess…